Temocaprilat

This classification denotes an ace inhibitor with the molecular formula C21H24N2O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2D6A12Q12R, chemically known as 1,4-thiazepine-4(5h)-acetic acid, 6-((1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-, (2s-(2alpha,6beta(r*)))- but generally known as temocaprilat, which bears US NIH Compound Identifier 71324. European Medicines Agency schedules Temocaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10885MIG. The term TEMOCAPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). TEMOCAPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule temocaprilat under HS 29349990 and SITC 51579. As of Q4 2014, TEMOCAPRILAT remains the US FDA Preferred Term for this commodity. Temocaprilat bears US NLM identifiers UMLS ID C0646101 and NCI Concept Code C75023. SMILES: S1C(CN(C(=O)C(NC(CCc2ccccc2)C(=O)O)C1)CC(=O)O)c1sccc1.